|
C4ORF29 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.30930000011398E-07 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
9.11110000001436E-07 |
| Normal-vs-Stage2 |
1.210570E-01 |
| Normal-vs-Stage3 |
4.42919999998903E-06 |
| Normal-vs-Stage4 |
1.132240E-02 |
| Stage1-vs-Stage2 |
4.753600E-01 |
| Stage1-vs-Stage3 |
1.400420E-01 |
| Stage1-vs-Stage4 |
4.617000E-01 |
| Stage2-vs-Stage3 |
1.141230E-01 |
| Stage2-vs-Stage4 |
3.371400E-01 |
| Stage3-vs-Stage4 |
8.412400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
9.84369999956769E-08 |
| Normal-vs-AfricanAmerican |
1.562090E-03 |
| Normal-vs-Asian |
3.083700E-03 |
| Caucasian-vs-AfricanAmerican |
3.398400E-01 |
| Caucasian-vs-Asian |
7.264200E-01 |
| AfricanAmerican-vs-Asian |
5.538000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.1072999994699E-07 |
| Normal-vs-Female |
2.986200E-04 |
| Male-vs-Female |
3.825600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
8.372900E-04 |
| Normal-vs-Extreme_Weight |
2.35249999480658E-08 |
| Normal-vs-Obese |
7.68570000000413E-05 |
| Normal-vs-Extreme_Obese |
2.632600E-01 |
| Normal_Weight-vs-Extreme_Weight |
2.483600E-01 |
| Normal_Weight-vs-Obese |
9.857000E-01 |
| Normal_Weight-vs-Extreme_Obese |
6.008800E-01 |
| Extreme_Weight-vs-Obese |
1.916210E-01 |
| Extreme_Weight-vs-Extreme_Obese |
1.864810E-01 |
| Obese-vs-Extreme_Obese |
5.473800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.52237999999638E-05 |
| Normal-vs-Age(41-60Yrs) |
8.17150000000932E-05 |
| Normal-vs-Age(61-80Yrs) |
1.46540000023343E-07 |
| Normal-vs-Age(81-100Yrs) |
1.52369999999458E-05 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.733900E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.923800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.470800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.145360E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.190400E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.023400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.30300000000805E-06 |
| Normal-VS-Type2 PRCC |
6.20580000054716E-07 |
| Normal-VS-KIRP CIMP |
1.4400000000192E-06 |
| Normal-VS-Unclassified PRCC |
9.235500E-03 |
| Type1 PRCC-VS-Type2 PRCC |
2.791800E-01 |
| Type1 PRCC-VS-KIRP CIMP |
6.194000E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
5.539800E-01 |
| Type2 PRCC-VS-KIRP CIMP |
1.948810E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
2.311400E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
7.267600E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.34960004177987E-09 |
| Normal-vs-N1 |
2.12840000002323E-06 |
| Normal-vs-N2 |
2.3970999999956E-05 |
| N0-vs-N1 |
9.224000E-01 |
| N0-vs-N2 |
1.152400E-01 |
| N1-vs-N2 |
1.688560E-01 |
|
|
